Habelo

Habelo is a biotechnology company focused on the development and commercialization of therapies for age-related muscle loss, or sarcopenia. The company was founded by Dr. George Roth, a former senior scientist at the National Institute on Aging, to translate longevity research into clinical practice. Habelo's primary offering is a proprietary, prescription-only treatment designed to help older adults regain muscle mass, strength, and physical function. By targeting the underlying biological causes of muscle wasting, Habelo aims to extend the healthspan of the aging population. The company operates a specialized platform that combines clinical research with a direct-to-patient medical model.